← Eichor
Condition: Human Immunodeficiency Virus Hiv Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Human Immunodeficiency Virus Hiv

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The DART DELIVER-02 Study
Phase 1 · 3 location(s) · University of North Carolina, Chapel Hill · NCT07217379Quitting Matters Human Immunodeficiency Virus Hybrid Trial
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06883097Strategies to AchieVe Viral Suppression for Youth With HIV
NA · 1 location(s) · Johns Hopkins University · NCT06886971Integrating HIV Prevention With TB Household Contact Evaluation in Uganda
NA · 1 location(s) · University of Washington · NCT07119359Text Education About Cardiovascular Health and HIV (TEACH-HIV)
NA · 2 location(s) · University of California, San Francisco · NCT05642858Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Foll
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05470491Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)
Phase N/A · 2 location(s) · MagIA Diagnostics · NCT07170748Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India
NA · 3 location(s) · University of California, Irvine · NCT07209917Low Dose Naltrexone for Pain in Patients With HIV
Phase 4 · 3 location(s) · Emory University · NCT05537935Integrated Mental Health Care for Pregnant Women With HIV in Kenya: The Tunawiri Study
NA · 1 location(s) · University of Colorado, Denver · NCT06117163Inflammation and Depression in People With HIV
Phase 2 · 2 location(s) · Emory University · NCT05849038A Phase Ⅱa Clinical Study of CL-197 Capsules
Phase 2 · 1 location(s) · Henan Genuine Biotech Co., Ltd. · NCT07308782Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
NA · 2 location(s) · Boston University · NCT06088277German Centre for Infection Research HIV Translational Platform
Phase N/A · 1 location(s) · University Hospital of Cologne · NCT02149004A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
Phase 2 · 10 location(s) · Naga P. Chalasani · NCT07143968Mass Balance and Absolute Oral Bioavailability of [14C]VH4524184
Phase 1 · 1 location(s) · ViiV Healthcare · NCT07636928Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretrovir
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06819176Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation P
Phase 4 · 1 location(s) · New York University · NCT06598397Exploration of the Variability of Exposure to Antiretroviral Treatment in Hair With a View to Validating Its Value as a
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT07062614Persuasive Health Communication Intervention for HIV/HCV
NA · 1 location(s) · University of South Florida · NCT05968573HIV Prevention With PrEP Among People on Opioid Replacement Therapy
Phase 4 · 6 location(s) · Cara Spence · NCT07160075DOR/TDF/3TC COmpared With BIC/FTC/TAF in ART-Naïve People Living With HIV and Overweight or Obesity
Phase 3 · 1 location(s) · José Antonio Mata Marín · NCT07075146Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism
Phase N/A · 1 location(s) · National Taiwan University Hospital · NCT04760574Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05419024The Trans-Led Care Study
NA · 1 location(s) · Illinois Institute of Technology · NCT06880705Baricitinib for Reduction of HIV - CNS
Phase 2 · 2 location(s) · William Tyor · NCT05452564Evaluation of Safety and Immunogenicity of Ad26.Mos4.HIV and CH505 TF chTrimer Combination in Healthy Adults
Phase 1 · 1 location(s) · U.S. Army Medical Research and Development Command · NCT06205056Pre-exposure Prophylaxis (PrEP) for Health
NA · 2 location(s) · Brown University · NCT04430257Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older
NA · 1 location(s) · Wake Forest University Health Sciences · NCT05858034Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT03300830
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.